In this interview held during the Transcatheter Valve Therapeutics Meeting in Vancouver, Canada in June 2014, Heart editor Catherine Otto talks to Ted Feldman, Evanston Hospital.

Professor Feldman is one of the leaders in the field of transcatheter mitral valve repair, and discusses patient selection, procedural aspects and intermediate term outcomes with this exciting new therapy.

Clinicians will find this brief summary useful as this new technique offers a therapeutic options for many of our patients with mitral regurgitation who are not candidates for conventional open surgery.

For more information about intervention for patients with severe mitral regurgitation, readers can consult several recent articles in Heart:

A systematic review on the safety and efficacy of percutaneous edge-to-edge mitral valve repair with the MitraClip system for high surgical risk candidates http://goo.gl/0MBpMF

2014 ACC/AHA valve guidelines: earlier intervention for chronic mitral regurgitation http://goo.gl/dXDX0U

Valvular heart disease: The evolving role of multimodality imaging in valvular heart disease http://goo.gl/IcJdqW

Almanac 2013: Novel non-coronary cardiac interventions http://goo.gl/OpoHGC

Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry http://goo.gl/DqHBAi